Day One Biopharmaceuticals Inc (DAWN)vsRevolution Medicines Inc (RVMD)
DAWN
Day One Biopharmaceuticals Inc
$21.53
0.00%
HEALTHCARE · Cap: $2.22B
RVMD
Revolution Medicines Inc
$155.69
+3.11%
HEALTHCARE · Cap: $32.71B
Smart Verdict
WallStSmart Research — data-driven comparison
Day One Biopharmaceuticals Inc generates 21218% more annual revenue ($158.18M vs $742,000). RVMD leads profitability with a 0.0% profit margin vs -67.8%. DAWN earns a higher WallStSmart Score of 30/100 (F).
DAWN
Avoid30
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 83.9% year-over-year
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
ROE of -22.7% — below average capital efficiency
Negative free cash flow — burning cash
Currently unprofitable
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : DAWN
The strongest argument for DAWN centers on Revenue Growth. Revenue growth of 83.9% demonstrates continued momentum.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : DAWN
The primary concerns for DAWN are EPS Growth, Return on Equity, Free Cash Flow.
Bear Case : RVMD
The primary concerns for RVMD are EPS Growth, Profit Margin, Operating Margin.
Key Dynamics to Monitor
DAWN profiles as a hypergrowth stock while RVMD is a value play — different risk/reward profiles.
RVMD carries more volatility with a beta of 1.41 — expect wider price swings.
DAWN is growing revenue faster at 83.9% — sustainability is the question.
DAWN generates stronger free cash flow (-18M), providing more financial flexibility.
Bottom Line
DAWN scores higher overall (30/100 vs 24/100) and 83.9% revenue growth. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Day One Biopharmaceuticals Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and markets targeted therapies for patients with genetically defined cancers. The company is headquartered in South San Francisco, California.
Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?